-transparent.png){kind=logo}
Erbstatin inhibited the kinase activity of the receptor for epidermal growth factor in cultured A431 cells, while it did not alter turnover of the receptor protein. It also inhibited autophosphorylation of the src gene product p60src in Rous sarcoma virus-infected normal rat kidney cells. Erbstatin did not inhibit the binding of epidermal growth factor to its receptor but did inhibit internalization of epidermal growth factor-receptor complexes. It did not inhibit the epidermal growth factor-stimulated phosphatidylinositol turnover in A431 cells. Thus, erbstatin inhibited two oncogene product-related tyrosine protein kinases in situ and thus is a useful tool to study the role of tyrosine protein kinase.
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
November 1990,
Biochemical pharmacology,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
May 1993,
The Journal of antibiotics,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
November 1990,
Blood,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
July 1993,
Biochemical and biophysical research communications,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
March 1992,
Biochemistry international,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
February 2009,
Pflugers Archiv : European journal of physiology,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
June 1992,
Biochemical pharmacology,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
August 1985,
Biochemical and biophysical research communications,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
September 1997,
Biochemical and biophysical research communications,
M Imoto, and
K Umezawa, and
T Sawa, and
T Takeuchi, and
H Umezawa
January 1994,
The International journal of biochemistry,
